Related Experiment Videos
Isolated trochlear nerve palsy in patients with multiple sclerosis
D M Jacobson1, M L Moster, E R Eggenberger
1Department of Neurology, Marshfield Clinic, WI 54449, USA.
Abstract:
The authors describe five patients with trochlear nerve palsy and MS to characterize this rare association. In two patients, trochlear nerve palsy was the initial clinical manifestation of MS. In the other three patients, this sign occurred after previous neurologic events. MRI did not identify a lesion of the fourth nerve nucleus or fascicle. Ophthalmoplegia resolved within 2 months in four of the five patients. A reason this association is rare is that the fascicular course of the trochlear nerve is exposed to little myelin.
Insights
Trochlear nerve palsy is a rare initial sign of Multiple Sclerosis (MS). This study details five MS patients with trochlear nerve palsy, noting its frequent resolution and lack of identifiable lesions on MRI.
Area of Science:
- Neuro-ophthalmology
- Neuroimmunology
- Demyelinating Diseases
Background:
- Multiple Sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system.
- Trochlear nerve palsy, affecting eye movement, is an uncommon neurological manifestation.
- Understanding rare associations aids in early diagnosis and management of MS.
Observation:
- Five patients with trochlear nerve palsy and MS were analyzed.
- In two patients, trochlear nerve palsy was the first MS symptom.
- In three patients, it occurred after prior neurological events.
Findings:
- Magnetic Resonance Imaging (MRI) did not reveal lesions in the fourth nerve nucleus or fascicle.
- Ophthalmoplegia (eye muscle paralysis) resolved within two months in four out of five patients.
- The rarity of this association may be due to the trochlear nerve's limited myelin exposure.
Implications:
- Trochlear nerve palsy should be considered in the differential diagnosis of MS, especially in young adults.
- Early recognition can lead to timely MS diagnosis and treatment initiation.
- Further research is needed to elucidate the pathophysiology of this rare neurological sign in MS.